DName-iT Holdings Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DName-iT Holdings Limited - overview
Location
Belfast, -, UK
Primary Industry
Biotechnology
About
Based in Belfast, UK, DName-iT Holdings Limited operates as a biotechnology platform that engages in gene sequencing for accurate treatment. The company is a spin-off of the university KULeuven (Belgium) and was founded by its CSO, Harry Cuppens. In June 2023, DName-iT Holdings Limited raised GBP 0. 5 million in venture funding led by EMV Capital, with participation from BNP Paribas, K.
U. Leuven Research & Development, and KBC Group. As of 2023, the company is led by its CEO, Kevin Dean. DName-iT Holdings offers various tools and accessory consumables used for controlling the workflow of genetic tests through amplification or capture by hybridization with oligonucleotides.
The company uses next-generation sequencing (NGS) and DNA barcodes for the detection of sample swaps, contamination, and the genetic testing process by switching or tube mislabelling. The company’s product portfolio includes DName® Barcodes, Accessory Oligos, DName® Database, and DName® Software. The company plans to use the June 2023 funding to accelerate its research and development.
Current Investors
K.U. Leuven Research & Development, KBC Group, BNP Paribas
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.dnameit.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.